NASDAQ:ACRV

Acrivon Therapeutics (ACRV) Price Target & Analyst Ratings

$9.56

-0.34 (-3.43%)

(As of 09/29/2023 ET)

Compare

Today's Range: $9.55
▼
$9.79
50-Day Range: $8.95
▼
$12.54
52-Week Range: $8.06
▼
$25.47

Volume: 7,153 shs
Average Volume: 12,299 shs
Market Capitalization: $211.02 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $22.86

Acrivon Therapeutics Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 9 Analyst Ratings

Consensus Analyst Price Target

$22.86
139.09% Upside

High Prediction	$26.00
Average Prediction	$22.86
Low Prediction	$17.00

Type	Current 10/1/22 to 10/1/23	1 Month Ago 9/1/22 to 9/1/23	3 Months Ago 7/3/22 to 7/3/23	1 Year Ago 10/1/21 to 10/1/22
Consensus Rating	Buy	Buy	Buy	N/A
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	9 Buy rating(s)	9 Buy rating(s)	8 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$22.86	$22.86	$23.00	N/A
Predicted Upside	139.09% Upside	85.87% Upside	89.59% Upside	N/A

Get Acrivon Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ACRV and its competitors with MarketBeat's FREE daily newsletter.

ACRV Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ACRV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Acrivon Therapeutics Stock vs. The Competition

Type	Acrivon Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.66	2.49
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	139.09% Upside	869.81% Upside	698.21% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/6/2023	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00	+68.07%
8/18/2023	Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$26.00	+135.51%
6/1/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$25.00	+101.29%
5/8/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$25.00	+99.52%
4/27/2023	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$22.00	+76.00%
12/12/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$17.00	+36.00%
12/12/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform
12/11/2022	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$25.00	+100.00%

(Data available from 10/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

ACRV Price Target - Frequently Asked Questions

What is Acrivon Therapeutics's consensus rating and price target?: According to the issued ratings of 9 analysts in the last year, the consensus rating for Acrivon Therapeutics stock is Buy based on the current 9 buy ratings for ACRV. The average twelve-month price prediction for Acrivon Therapeutics is $22.86 with a high price target of $26.00 and a low price target of $17.00. Learn more on ACRV's analyst rating history.
Do Wall Street analysts like Acrivon Therapeutics more than its competitors?: Analysts like Acrivon Therapeutics more than other Medical companies. The consensus rating for Acrivon Therapeutics is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how ACRV compares to other companies.
Does Acrivon Therapeutics's stock price have much upside?: According to analysts, Acrivon Therapeutics's stock has a predicted upside of 87.38% based on their 12-month price targets.

What analysts cover Acrivon Therapeutics?: Acrivon Therapeutics has been rated by HC Wainwright, and Jonestrading in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:ACRV) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial